NCT05707910 2026-03-09
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
West China Hospital
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT07004244 2025-06-24
Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies
Sichuan University
Phase 1 Recruiting
NCT06612632 2024-09-25
Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Recruiting
NCT05253105 2022-05-31
A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Withdrawn